Hims & Hers Health (HIMS) Reports Q1: Everything You Need To Know Ahead Of Earnings

Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting results this Monday after the bell. Here’s what to expect.

Hims & Hers Health met analysts’ revenue expectations last quarter, reporting revenues of $617.8 million, up 28.4% year on year. It was a mixed quarter for the company, with full-year revenue guidance exceeding analysts’ expectations but revenue guidance for next quarter missing analysts’ expectations significantly. It added 40,000 customers to reach a total of 2.51 million.

Is Hims & Hers Health a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, the market is expecting Hims & Hers Health’s revenue to grow 5.2% year on year, slowing from the 111% increase it recorded in the same quarter last year.Hims & Hers Health Total Revenue

The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Hims & Hers Health has missed Wall Street’s revenue estimates multiple times over the last two years.

Looking at Hims & Hers Health’s peers in the healthcare technology segment, some have already reported their Q1 results, giving us a hint as to what we can expect. GoodRx’s revenues decreased 4.4% year on year, beating analysts’ expectations by 4.9%, and Tandem Diabetes reported revenues up 5.5%, topping estimates by 3.2%. GoodRx traded up 9.9% following the results while Tandem Diabetes was down 16.3%.

Read our full analysis of GoodRx’s results here and Tandem Diabetes’s results here.

There has been positive sentiment among investors in the healthcare technology segment, with share prices up 6.1% on average over the last month. Hims & Hers Health is up 49.6% during the same time and is heading into earnings with an average analyst price target of $26.04 (compared to the current share price of $29.07).

WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.

This is what the early days of Palantir looked like before it became a $437 billion giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.

View Comments